Targeted Oncology26 分钟
Jacobs and Peers Consider Third-Line Treatment in Relapsed/Refractory CLL
During a Case-Based Roundtable® event, Ryan W. Jacobs, MD, discussed a patient who received 2 prior lines of therapy for ...